De Burlo Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,520
| Closed | -$611K | – | 86 |
|
|
2023
Q4 | $611K | Hold |
10,520
| – | – | 0.11% | 67 |
|
|
2023
Q3 | $611K | Sell |
10,520
-8,430
| -44% | -$489K | 0.11% | 67 |
|
|
2023
Q2 | $1.21M | Sell |
18,950
-300
| -2% | -$19.2K | 0.2% | 58 |
|
|
2023
Q1 | $1.33M | Sell |
19,250
-550
| -3% | -$38.1K | 0.26% | 58 |
|
|
2022
Q4 | $1.42M | Buy |
19,800
+100
| +0.5% | +$7.2K | 0.32% | 47 |
|
|
2022
Q3 | $1.4M | Sell |
19,700
-2,427
| -11% | -$173K | 0.33% | 48 |
|
|
2022
Q2 | $1.7M | Buy |
22,127
+1,477
| +7% | +$114K | 0.49% | 23 |
|
|
2022
Q1 | $1.51M | Sell |
20,650
-3,100
| -13% | -$226K | 0.28% | 50 |
|
|
2021
Q4 | $1.48M | Sell |
23,750
-3,600
| -13% | -$224K | 0.22% | 64 |
|
|
2021
Q3 | $1.62M | Buy |
27,350
+100
| +0.4% | +$5.92K | 0.26% | 60 |
|
|
2021
Q2 | $1.82M | Hold |
27,250
| – | – | 0.29% | 54 |
|
|
2021
Q1 | $1.72M | Sell |
27,250
-500
| -2% | -$31.6K | 0.31% | 55 |
|
|
2020
Q4 | $1.72M | Hold |
27,750
| – | – | 0.28% | 51 |
|
|
2020
Q3 | $1.67M | Buy |
+27,750
| New | +$1.67M | 0.3% | 52 |
|
|
2016
Q4 | – | Sell |
-36,387
| Closed | -$1.96M | – | 98 |
|
|
2016
Q3 | $1.96M | Sell |
36,387
-115,300
| -76% | -$6.21M | 0.54% | 65 |
|
|
2016
Q2 | $11.2M | Buy |
151,687
+65,000
| +75% | +$4.78M | 2.7% | 8 |
|
|
2016
Q1 | $5.54M | Sell |
86,687
-27,500
| -24% | -$1.76M | 1.6% | 21 |
|
|
2015
Q4 | $7.85M | Buy |
114,187
+69,800
| +157% | +$4.8M | 1.85% | 21 |
|
|
2015
Q3 | $2.63M | Buy |
44,387
+9,000
| +25% | +$533K | 0.62% | 54 |
|
|
2015
Q2 | $2.35M | Buy |
+35,387
| New | +$2.35M | 0.49% | 64 |
|